Xiaohui Chi
Overview
Explore the profile of Xiaohui Chi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
283
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Du M, Chi C, Xiong L, Rong J, Yi M, Zhao Q, et al.
Infect Drug Resist
. 2025 Jan;
17:5855-5866.
PMID: 39741887
Purpose: is a conditioned pathogen in the medical setting and mainly affects patients with cystic fibrosis. We found co-infection with complex (Bcc) in many patients with respiratory tract infections, including...
2.
Zhou Y, Guo L, Xiao T, Chen Y, Lv T, Wang Y, et al.
Microbes Infect
. 2024 Jun;
26(8):105373.
PMID: 38857786
Gut microbiota dysbiosis increases the susceptibility to Clostridioides difficile infection (CDI). In this study, we monitored C. difficile colonization (CDC) patients from no CDC status (CDN) to CDC status (CDCp)...
3.
Chen T, Wang Y, Chi X, Xiong L, Lu P, Wang X, et al.
Virulence
. 2024 May;
15(1):2349768.
PMID: 38736039
ST11 is the most common lineage among carbapenem-resistant (CRKP) infections in Asia. Diverse morphotypes resulting from genetic mutations are associated with significant differences in microbial characteristics among isolates. Here, we...
4.
Wang Y, Ma Y, Xiong L, Wang X, Zhou Y, Chi X, et al.
J Microbiol Immunol Infect
. 2024 Feb;
57(2):300-308.
PMID: 38350840
Purposes: This study determined the synergy of polymyxin B (POLB) and colistin (COL) with 16 other tested antimicrobial agents in the inhibition of multidrug-resistant Acinetobacter baumannii (MDR-AB). Methods: We used...
5.
Cao Y, Chi X, Chen G, Ji L, Zhang W
J Fam Psychol
. 2024 Feb;
38(3):411-420.
PMID: 38300533
Despite the well-established relationship between parenting and child aggression, the mechanisms by which children incur this risk and whether genetic sources contribute to the heterogeneity in their vulnerability are not...
6.
Wang X, Xiong L, Wang Y, Yang K, Xiao T, Chi X, et al.
Ann Clin Microbiol Antimicrob
. 2023 Dec;
22(1):107.
PMID: 38072972
Objective: To evaluate effect of inoculum size of extended-spectrum β-Lactamase (ESBL)-producing-, AmpC-producing-, and KPC-producing Escherichia coli and Klebsiella pneumoniae on the in vitro antibacterial effects of imipenem/relebactam (IMR) and ceftazidime/avibactam...
7.
Wang Y, Luo Q, Chen T, Chi X, Zhou Y, Fu H, et al.
Clin Microbiol Infect
. 2023 Jul;
29(10):1336.e1-1336.e8.
PMID: 37423426
Objectives: The emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) is a major clinical concern, and polymyxin B (PMB) is a 'last resort' antibiotic for its treatment. Understanding the effects of drug...
8.
Xiong L, Wang Y, Wang X, Zhou Y, Chi X, Chen T, et al.
Int J Antimicrob Agents
. 2023 Jun;
62(2):106877.
PMID: 37271474
In order to investigate ceftazidime/avibactam (CZA) resistance characteristics and mechanisms of bacteraemic Enterobacterales strains that had not been treated previously with CZA, 9708 strains were collected from 43 hospitals in...
9.
Bi J, Xu Y, Li S, Zhan G, Hua D, Tan J, et al.
Front Aging Neurosci
. 2023 Mar;
15:1108205.
PMID: 36875700
Objective: To investigate the role of gut microbiota and metabolites in POCD in elderly orthopedic patients, and screen the preoperative diagnostic indicators of gut microbiota in elderly POCD. Method: 40...
10.
Chen T, Wang Y, Zhou Y, Zhou W, Chi X, Shen P, et al.
Microbiol Spectr
. 2023 Jan;
11(1):e0110722.
PMID: 36622219
Carbapenem-resistant , especially carbapenemase-producing Klebsiella pneumoniae, is an urgent problem in health care facilities worldwide. K. pneumoniae isolates classified as sequence type 11 (ST11) are largely responsible for the spread...